A study of cancer patients attending a New York hospital details the rates of hospitalisation, morbidity and mortality associated with COVID-19

Breast cancer diagnosed within a year of a negative mammography may be more likely to metastasise than tumours detected during screening

Around 10% of cancer patients with suspected or confirmed COVID-19 die within 25 days of being admitted to hospital with symptoms

A study of cancer patients with COVID-19 has identified several risk factors for mortality

Head and neck squamous cell carcinoma patients who use nonsteroidal anti-inflammatory drugs during definitive chemoradiation may have improved overall survival

Adding capecitabine to trastuzumab emtansine did not improve the overall response rate for HER2-positive metastatic breast cancer

Apixaban may offer an oral alternative to subcutaneous enoxaparin for gynaecological cancer patients at risk of postoperative venous thromboembolism

Event-free survival in men undergoing radiotherapy with curative intent for localised intermediate- or high-risk prostate cancer does not predict overall survival